An interpretation of VTL's beta
How does VTL's size and industry impact its risk?
With a beta of 5.11, Vital Therapies is a stock that tends to experience more gains than the market during a growth phase and also a bigger reduction in value compared to the market during a broad downturn. Based on this beta value, VTL may be a stock for investors with a portfolio mainly made up of low-beta stocks.
Is VTL's cost structure indicative of a high beta?
A market capitalisation of USD $213.15M puts VTL in the category of small-cap stocks, which tends to possess higher beta than larger companies. However, VTL operates in the biotechnology industry, which has commonly demonstrated muted reactions to market-wide shocks.
Verde Bio Holdings Stock Forecast, "VBHI" Share Price Prediction Charts
An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive. I test VTL’s ratio of fixed assets to total assets in order to determine how high the risk is associated with this type of constraint.
KPIT Technologies Stock Forecast, "KPITTECH" Share Price Prediction Charts
JoetheDetailer — The predictions of this VBHI is so whacky!! One day prices where way up and now they are way down. I'm not sure I this...
Vodafone Idea Stock Forecast, "532822" Share Price Prediction Charts
PVS — Kindly refresh this stock with the current live data as it is not showing the current market stock price level.